Cargando…

Proline-Rich Protein Tyrosine Kinase 2 in Inflammation and Cancer

Focal adhesion kinase (FAK) and its homologous FAK-related proline-rich tyrosine kinase 2 (Pyk2) contain the same domain, exhibit high sequence homology and are defined as a distinct family of non-receptor tyrosine kinases. This group of kinases plays critical roles in cytoskeletal dynamics and cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiangdong, Bao, Yonghua, Guo, Yongchen, Yang, Wancai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977112/
https://www.ncbi.nlm.nih.gov/pubmed/29738483
http://dx.doi.org/10.3390/cancers10050139
_version_ 1783327307486724096
author Zhu, Xiangdong
Bao, Yonghua
Guo, Yongchen
Yang, Wancai
author_facet Zhu, Xiangdong
Bao, Yonghua
Guo, Yongchen
Yang, Wancai
author_sort Zhu, Xiangdong
collection PubMed
description Focal adhesion kinase (FAK) and its homologous FAK-related proline-rich tyrosine kinase 2 (Pyk2) contain the same domain, exhibit high sequence homology and are defined as a distinct family of non-receptor tyrosine kinases. This group of kinases plays critical roles in cytoskeletal dynamics and cell adhesion by regulating survival and growth signaling. This review summarizes the physiological and pathological functions of Pyk2 in inflammation and cancers. In particular, overexpression of Pyk2 in cancerous tissues is correlated with poor outcomes. Pyk2 stimulates multiple oncogenic signaling pathways, such as Wnt/β-catenin, PI3K/Akt, MAPK/ERK, and TGF-β/EGFR/VEGF, and facilitates carcinogenesis, migration, invasion, epithelial–mesenchymal transition and metastasis. Therefore, Pyk2 is a high-value therapeutic target and has clinical significance.
format Online
Article
Text
id pubmed-5977112
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-59771122018-05-31 Proline-Rich Protein Tyrosine Kinase 2 in Inflammation and Cancer Zhu, Xiangdong Bao, Yonghua Guo, Yongchen Yang, Wancai Cancers (Basel) Review Focal adhesion kinase (FAK) and its homologous FAK-related proline-rich tyrosine kinase 2 (Pyk2) contain the same domain, exhibit high sequence homology and are defined as a distinct family of non-receptor tyrosine kinases. This group of kinases plays critical roles in cytoskeletal dynamics and cell adhesion by regulating survival and growth signaling. This review summarizes the physiological and pathological functions of Pyk2 in inflammation and cancers. In particular, overexpression of Pyk2 in cancerous tissues is correlated with poor outcomes. Pyk2 stimulates multiple oncogenic signaling pathways, such as Wnt/β-catenin, PI3K/Akt, MAPK/ERK, and TGF-β/EGFR/VEGF, and facilitates carcinogenesis, migration, invasion, epithelial–mesenchymal transition and metastasis. Therefore, Pyk2 is a high-value therapeutic target and has clinical significance. MDPI 2018-05-08 /pmc/articles/PMC5977112/ /pubmed/29738483 http://dx.doi.org/10.3390/cancers10050139 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Zhu, Xiangdong
Bao, Yonghua
Guo, Yongchen
Yang, Wancai
Proline-Rich Protein Tyrosine Kinase 2 in Inflammation and Cancer
title Proline-Rich Protein Tyrosine Kinase 2 in Inflammation and Cancer
title_full Proline-Rich Protein Tyrosine Kinase 2 in Inflammation and Cancer
title_fullStr Proline-Rich Protein Tyrosine Kinase 2 in Inflammation and Cancer
title_full_unstemmed Proline-Rich Protein Tyrosine Kinase 2 in Inflammation and Cancer
title_short Proline-Rich Protein Tyrosine Kinase 2 in Inflammation and Cancer
title_sort proline-rich protein tyrosine kinase 2 in inflammation and cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977112/
https://www.ncbi.nlm.nih.gov/pubmed/29738483
http://dx.doi.org/10.3390/cancers10050139
work_keys_str_mv AT zhuxiangdong prolinerichproteintyrosinekinase2ininflammationandcancer
AT baoyonghua prolinerichproteintyrosinekinase2ininflammationandcancer
AT guoyongchen prolinerichproteintyrosinekinase2ininflammationandcancer
AT yangwancai prolinerichproteintyrosinekinase2ininflammationandcancer